Edomex Leads Investment in Mexico's Pharmaceutical & Biotech Industry

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Mexico's pharmaceutical market has steadily grown over the past decade and is projected to be worth more than $13 billion by 2028, according to PharmaBoardroom. Industrial Info is tracking 239 capital-spending projects, totaling $1.27 billion in value, in Mexico's Pharmaceutical & Biotech Industry.

The State of Mexico (Edomex) accounts for 118 of these projects, followed by Distrito Federal (Mexico City) and Queretaro. Together, these three regions represent $880 million, or 70% of the total spending. Final-formulation projects account for the bulk of the investments.

Subscribers to Industrial Info's Pharmaceutical & Biotech Project Database can click here for a list of capital-spending projects in Mexico's Pharmaceutical & Biotech Industry.

Click on the image at right for a graph detailing capital-spending projects in Mexico's Pharmaceutical & Biotech Industry, by industry sector.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.